Aptiva Medical, a Greenleaf Ventures portfolio company, announced on October 7 the completion of its acquisition of VeraMed Health for an undisclosed price.
VeraMed Health specializes in providing diabetic supplies (such as continuous glucose monitoring systems) and urinary catheters. It offers free home delivery, insurance billing and patient support services as a Medicare-approved supplier.
Aptiva Medical is a national leader in the home delivery of continuous glucose monitors, diabetes testing supplies and specialty transplant medications. The company provides end-to-end patient support, from prescription coordination and insurance billing to convenient home delivery. It partners with physicians, payors and patients to improve adherence and outcomes. Aptiva Medical is headquartered in Fort Lauderdale, Florida.
“This acquisition aligns perfectly with Aptiva Medical’s mission to build a leading, nationwide direct-to-patient CGM business,” said David Wallace, Co-Founder and Managing Partner of Greenleaf Ventures. “The VeraMed team has built an excellent foundation of patient care, and Aptiva Medical will ensure a seamless transition for every patient while continuing to raise the bar on service and efficiency.”
According to data captured in the LevinPro HC database, this transaction marks the 28th healthcare product distributor acquisition of the year. The most active buyer in the space is Asker Healthcare Group, which has announced six acquisitions in 2025, so far. The healthcare product distributor transaction with the largest purchase price of the year is UPS’ acquisition of Andlauer Healthcare Group Inc. for $1.6 billion.
